The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Becotide Evohaler 100 micrograms, Pressurised Inhalation Solution

GlaxoSmithKline (Ireland) LimitedPA1077/042/007

Main Information

Trade NameBecotide Evohaler 100 micrograms, Pressurised Inhalation Solution
Active SubstancesBeclometasone dipropionate
Dosage FormPressurised inhalation, solution
Licence HolderGlaxoSmithKline (Ireland) Limited
Licence NumberPA1077/042/007

Group Information

ATC CodeR03BA Glucocorticoids
R03BA01 beclometasone


License statusAuthorised
Licence Issued07/01/2005
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back